Weekly cisplatin fails to show fewer serious side effects in p16-negative head and neck cancer
Physicians typically use either a higher dose of cisplatin given every three weeks or a lower dose given weekly in combination with radiation to treat locally advanced head and neck cancer. However, before NRG-HN009, there ...
1 hour ago
0
0









